Vaccines, blood, antisera, toxins and cultures in   Pakistan

Exports In 2023, Pakistan exported $244k in Vaccines, blood, antisera, toxins and cultures, making it the 122nd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 657th most exported product in Pakistan. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Pakistan are: Philippines ($109k), South Africa ($38k), United States ($27.6k), Botswana ($23.1k), and Germany ($11k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Pakistan between 2022 and 2023 were Philippines ($43.7k), South Africa ($38k), and United States ($27.6k).

Imports In 2023, Pakistan imported $368M in Vaccines, blood, antisera, toxins and cultures, becoming the 56th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 21st most imported product in Pakistan. Pakistan imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($132M), India ($52.1M), United States ($35.5M), France ($29.1M), and Indonesia ($23.7M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Pakistan between 2022 and 2023 were Indonesia ($13M), Bangladesh ($1.81M), and South Korea ($1.73M).